FHCCX
Price
$36.83
Change
-$4.85 (-11.64%)
Updated
Feb 3 closing price
Net Assets
3.25B
JNGLX
Price
$81.82
Change
+$6.95 (+9.28%)
Updated
Feb 3 closing price
Net Assets
5.36B
Interact to see
Advertisement

FHCCX vs JNGLX

Header iconFHCCX vs JNGLX Comparison
Open Charts FHCCX vs JNGLXBanner chart's image
Fidelity Advisor Health Care C
Price$36.83
Change-$4.85 (-11.64%)
VolumeN/A
Net Assets3.25B
Janus Henderson Global Life Sciences D
Price$81.82
Change+$6.95 (+9.28%)
VolumeN/A
Net Assets5.36B
FHCCX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
FHCCX vs. JNGLX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHCCX is a Hold and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5.36B vs. FHCCX (3.25B). JNGLX pays higher dividends than FHCCX: JNGLX (0.43) vs FHCCX (0.00). FHCCX was incepted earlier than JNGLX: FHCCX (28 years) vs JNGLX (27 years). FHCCX (1.68) is less costly to investors than JNGLX (0.80). FHCCX is a more actively managed with annual turnover of: 52.00 vs. JNGLX (30.00). FHCCX has a lower initial minimum investment than JNGLX: FHCCX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : 15.11 vs. FHCCX (-9.50). JNGLX return over 5 years is better than : 15.42 vs. FHCCX (-27.46).
FHCCXJNGLXFHCCX / JNGLX
Total Expense Ratio1.680.80210%
Annual Report Gross Expense Ratio1.680.80210%
Fund Existence28 years27 years-
Gain YTD0.8141.02579%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.25B5.36B61%
Annual Yield % from dividends0.000.43-
Returns for 1 year-9.5015.11-63%
Returns for 3 years-15.8623.72-67%
Returns for 5 years-27.4615.42-178%
Returns for 10 years37.5698.2538%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDFX59.760.32
+0.54%
Marsico Midcap Growth Focus Instl
FBTTX34.88N/A
N/A
Fidelity Advisor Biotechnology M
TDFIX9.25-0.02
-0.22%
Transamerica Sustainable Equity Inc I
HROAX12.40-0.07
-0.56%
M3Sixty Income and Opportunity A
VPRAX26.68-0.19
-0.71%
VY® T. Rowe Price Capital Apprec R6